D-0123-2018 Class I Terminated
FDA drug recall D-0123-2018 was initiated by Pfizer Inc. on Aug 30, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: glass particulate found in vial The recall status is terminated (terminated Nov 8, 2018). Affected quantity: 102,500 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Aug 30, 2017
- Termination Date
- Nov 8, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 102,500 vials
Product description
Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02
Reason for recall
Presence of Particulate Matter: glass particulate found in vial
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot: 632153A; Exp. 03/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0123-2018
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.